DOCSLIB.ORG

Immunochemical Localization of Parathyroid Hormone in Cancer Tissue from Patients with Ectopic Hyperparathyroidism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Immunochemical Localization of Parathyroid Hormone in Cancer Tissue from Patients with Ectopic Hyperparathyroidism Immunochemical Localization of Parathyroid Hormone in Cancer Tissue from Patients with Ectopic Hyperparathyroidism Genaro M. A. Palmieri, … , Robert E. Nordquist, Gilbert S. Omenn J Clin Invest. 1974;53(6):1726-1735. https://doi.org/10.1172/JCI107724. Research Article Immunoreactive parathyroid hormone (PTH) in nonparathyroid malignant tumors associated with hypercalcemia and hypophosphatemia in the absence of demonstrable bone metastases was determined by radioimmunoassay and immunofluorescent techniques. Six of seven tumors contained material with immunological cross-reactivity to bovine PTH by radioimmunoassay and immunofluorescence. The intensity of the immunofluorescent stain varied considerably in the different tumors. From 15 to 90% of neoplastic cells were stained specifically with fluorescein-labeled anti-PTH. In contrast, normal parathyroid glands and parathyroid adenomas showed uniform distribution of immunofluorescence in all parenchymal cells. In one malignant tumor, PTH was localized also by immunoautoradiography. In every case PTH was detected only in the cytoplasm of parenchymal cells. One patient lacked detectable PTH in his tumor, yet showed regression of the hypercalcemia to normal values after removal of large masses of neoplastic tissue and recurrence of hypercalcemia when new growth occurred. Dilutional radioimmunoassay curves of nonparathyroid malignant tumors were in most cases different from those obtained with extracts of normal parathyroid glands and parathyroid adenomas. Although both nonparathyroid neoplasmas and parathyroid extracts demonstrated immunoheterogeneity by gel filtration, greater heterogeneity was found in nonparathyroid malignant tumors. In those tumors in which immunological cross-reactivity to PTH was detected, the capability of secreting PTH may be restricted to derepressed cell clones amidst other neoplastic cells, whereas the greater heterogeneity of ectopic PTH may […] Find the latest version: https://jci.me/107724/pdf Immunochemical Localization of Parathyroid Hormone in Cancer Tissue from Patients with Ectopic Hyperparathyroidism GENARO M. A. PALMIERI, ROBERT E. NORDQUIST, and GILBERT S. OMENN From the Veterans Administration Hospital, Oklahoma Medical Research Foundation, Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104; and the Department of Medicine, University of Washington Medical School, Seattle, Washington 98105 A B S T R A C T Immunoreactive parathyroid hormone from those obtained with extracts of normal parathyroid (PTH) in nonparathyroid malignant tumors associated glands and parathyroid adenomas. Although both non- with hypercalcemia and hypophosphatemia in the ab- parathyroid neoplasms and parathyroid extracts demon- sence of demonstrable bone metastases was determined strated immunoheterogeneity by gel filtration, greater by radioimmunoassay and immunofluorescent techniques. heterogeneity was found in nonparathyroid malignant Six of seven tumors contained material with immuno- tumors. logical cross-reactivity to bovine PTH by radioimmuno- In those tumors in which immunological cross-reactiv- assay and immunofluorescence. The intensity of the ity to PTH was detected, the capability of secreting immunofluorescent stain varied considerably in the dif- PTH may be restricted to derepressed cell clones amidst ferent tumors. From 15 to 90% of neoplastic cells were other neoplastic cells, whereas the greater heterogeneity stained specifically with fluorescein-labeled anti-PTH. of ectopic PTH may reflect hormone cleavage by proteo- In contrast, normal parathyroid glands and parathyroid lytic enzymes in the tumor that is less specific than the adenomas showed uniform distribution of immunofluo- Pro-PTH cleaving enzyme in the parathyroids. rescence in all parenchymal cells. In one malignant tu- mor, PTH was localized also by immunoautoradiog- raphy. In every case PTH was detected only in the INTRODUCTION cytoplasm of parenchymal cells. One patient lacked de- Nonparathyroid malignant tumors in patients without tectable PTH in his tumor, yet showed regression of skeletal metastasis may be associated with hypercalcemia, the hypercalcemia to normal values after removal of hypophosphatemia, and clinical complications indis- large masses of neoplastic tissue and recurrence of hy- tinguishable from the syndrome of primary hyperpara- percalcemia when new growth occurred. thyroidism (1, 2). Various immunologic techniques have Dilutional radioimmunoassay curves of nonpara- demonstrated parathyroid hormone (PTH)1 in extracts thyroid malignant tumors were in most cases different of kidney, lung, liver, adrenal, parotid, spleen, and This work was presented in part at the 4th International breast tumors (3-6). A venous-arterial gradient for Congress of Endocrinology, Washington, D. C., 18-24 June PTH was found in cases due to hepatoma (5) and hyper- 1972. nephroma (7). Some malignancies may produce hu- Dr. Palmieri is a Clinical Investigator at the Veterans moral factors other than PTH capable of inducing hyper- Administration Hospital, Oklahoma City, Okla., and Dr. since is known that bone is stim- Omenn is the recipient of Career Development Award 43122 calcemia, it resorption from the National Institutes of Health. Address reprint ulated by a variety of biological agents, including 1,25- requests to Dr. Palmieri, Section of Endocrinology, De- hydroxycholecalciferol, vitamin A, and prostaglandin El partment of Medicine, University of Tennessee, Memphis, Tenn. 38163. 1Abbreviations used in this paper: HPTH, human para- Received for publication 26 July 1973 and in revised form thyroid tissue extract; PBS, phosphate-buffered saline; 16 November 1973. PTH, parathyroid hormone. 1726 The Journal of Clinical Investigation Volume 53 June 1974-1726-1735 (8). Gordan, Cantino, Erhardt, Hansen, and Lubich PTH (TCA-PTH, Wilson Labs., Chicago, Ill.). PTH in (9) related hypercalcemia to the production of a sterol plasma of normal subjects, patients with primary hyper- by some breast carcinomas, while Powell, Singer, Mur- parathyroidism, and patients with ectopic PTH syndrome ray, Minkin, and Potts (10) found no radioimmuno- was determined using an identical procedure in 500-pl samples of plasma. Antiserum GP 456-5-62 in a 1: 50,000 assayable PTH in extracts of 11 malignant tumors asso- dilution was also used in determinations of PTH in plasma. ciated with hypercalcemia and hypophosphatemia, five This antiserum is more sensitive than GP 012-6-23 for de- of which produced bone resorption in vitro. tection of circulating PTH. In malignant tumors secreting PTH, the Chromatographic fractionation. Lyophilized tissue ex- concentra- tracts resuspended in 3 ml of 0.2 M ammonium acetate tion of the hormone, based on dry weight measurements, buffer pH 4.6 were applied to a 2.0 X 90 cm Bio-Gel P-10 is 30-300 times lower than in parathyroid adenomas (4). column (Bio-Rad Laboratories, Richmond, Calif.) equili- The lower concentration of PTH in these nonpara- brated at 40C with 0.2 M ammonium acetate buffer pH thyroid neoplasms may be due to a slower rate of syn- 4.7. The flow rate was approximately 0.18 ml/min. 50-100- IAI samples of 1-ml fractions were diluted in 500 /Al of thesis or more rapid turnover in most of the cells or to hypoparathyroid plasma for radioimmunoassay. high levels of production by only a small fraction of the Morphological studies. Immunofluorescent studies were neoplastic cells. performed on normal parathyroid tissue, parathyroid ade- We present here studies of the content, intracellular nomas, ectopic hormone-secreting tumors, and in other localization, and tumors and tissues which contained no detectable para- chromatographic characteristics of thormone by radioimmunoassay. PTH in normal parathyroid glands, parathyroid ade- The tissues obtained were divided and cryostat sectioned nomas, and nonparathyroid malignant tumors associated on the face adjacent to the tissue taken for determination with ectopic hyperparathyroidism. of PTH. 7-/Am sections were fixed in acetone which was made basic by the addition of enough saturated NaOH in METHODS absolute ethyl alcohol to bring the pH to 7.5. After 10 min fixation in this solution the slides were air dried and Subjects. Ectopic production of PTH was investigated then washed with phosphate-buffered saline (PBS) at in patients with malignancies accompanied by hypercal- pH 7.2 (0.15 M NaCl, 0.01 M phosphate). Whole guinea cemia with no evidence of bone metastasis by X ray or at pig antiserum against bovine parathormone (GP 012-6-23) autopsy. In those cases in which a careful exploration of was diluted 1:10 with PBS, applied to the sections, and in- the parathyroid glands was performed at autopsy, the para- cubated in a humidified chamber at room temperature for thyroid glands were found to be normal (Table I). Normal 30 min. Increasing dilutions of the anti-PTH serum were parathyroid glands were obtained at autopsies of patients applied to sections of all tissues. No detectable immuno- without a history of metabolic or endocrine diseases. Para- fluorescence was observed with dilutions greater than 1: 100. thyroid adenomas were obtained during surgical explora- After incubation, the tissues were rinsed in three changes tion of patients with a diagnosis of primary hyperpara- of PBS for a total of 30 min and postcoupled with a 1: 30 thyroidism. dilution of fluorescein-labeled rabbit anti-guinea pig IgG Preparation of tissue extracts. Normal parathyroid glands, for 30 min. After
Load more

Recommended publications
  • Rosalyn S. Yalow, Phd a Personal & Scientific Memoir
    8/2/2012 54 th Annual Meeting - 2012 American Association of Physicists in Medicine Charlotte, NC Rosalyn S. Yalow, PhD A Personal & Scientific Memoir Stanley J. Goldsmith, MD Professor, Radiology & Medicine New York-Presbyterian Hospital Weill Cornell Medical College New York Rosalyn S. Yalow, PhD • Born July 19, 1921 New York City • NYC Public Schools [Walton HS, Bronx] • Hunter College: 1 st Physics Major; High Honors. BA, age 19 • Applied to Purdue University for Graduate School in Physics. Rejected as a New Yorker who was Jewish and a woman. • With onset of WWII, offered a Teaching Assistantship at University of Illinois College of Engineering in Champaign-Urbana. Only woman among 400 teaching fellows and faculty. 1 8/2/2012 Rosalyn S. Yalow, PhD • 1943: Married Aaron Yalow [a fellow Graduate Student]; 2 children: son, Benjamin; daughter, Elanna • 1945: PhD, Nuclear Physics; returned to NY; Taught Physics at Hunter College • Sought Research position; volunteered to work in Radiotherapy [now Radiation Oncology] at Columbia P&S • 1947: Moved to Bronx VA; part-time research in Radiotherapy Rosalyn S. Yalow, PhD • 1950: Employed full-time at at Bronx VA; expanded use of medical application of radioactive materials for Blood Volume determinations. Recommended adding a physician to program. Bernard Roswit, MD, Chairman, Radiation Therapy recruited a young physician who had completed training in Internal Medicine, Solomon A. Berson, MD. Rosalyn S. Yalow, PhD • 1950: Thus began an extraordinary collaboration with seminal papers in body spaces of electrolytes, albumin, globulins, thyroid iodine kinetics, role of 131 I in diagnosis and therapy of thyroid disease. • Directed skills in handling radioactivity to labeling insulin and assessing the mystery of why some diabetics [now known as maturity onset diabetics] had ample, even enlarged pancreatic islet cells, presumably secreting insulin, but nevertheless had diabetes.
    [Show full text]
  • A Rare Case of Invasive Pituitary Macroadenoma with Hemorrhage in MEN 1 Syndrome - a Case Report
    E.A. Ashok Kumar, M. Ravi Teja Raidu. A rare case of invasive pituitary macroadenoma with hemorrhage in MEN 1 syndrome - A case report. IAIM, 2021; 8(4): 106-117. Case Report A rare case of invasive pituitary macroadenoma with hemorrhage in MEN 1 syndrome - A case report E.A. Ashok Kumar1*, M. Ravi Teja Raidu2 1Professor, 2Assistant Professor Department of General Medicine, Malla Reddy Institute of Medical Sciences, Hyderabad, India *Corresponding author email: [email protected] International Archives of Integrated Medicine, Vol. 8, Issue 4, April, 2021. Available online at http://iaimjournal.com/ ISSN: 2394-0026 (P) ISSN: 2394-0034 (O) Received on: 25-03-2021 Accepted on: 05-04-2021 Source of support: Nil Conflict of interest: None declared. How to cite this article: E.A. Ashok Kumar, M. Ravi Teja Raidu. A rare case of invasive pituitary macroadenoma with hemorrhage in MEN 1 syndrome - A case report. IAIM, 2021; 8(4): 106-117. Abstract Multiple Endocrine Neoplasia (MEN) disorders are very rare. These are hereditary diseases which develop into a number of endocrine glands and result in tumor formation. The MENs are run in families because they are the exact consequence of genetic mutations and their symptoms are completely dissimilar dependent on the involving glands. Multiple endocrine neoplasia (MEN) is characterized by the occurrence of tumors involving two or more endocrine glands in a single patient. Four major forms of MEN, which are autosomal dominant disorders, are recognized and referred to as: MEN type 1 (MEN1), due to menin mutations; MEN2 (previously MEN2A) due to mutations of a tyrosine kinase receptor encoded by the rearranged during transfection (RET) protoncogene; MEN3 (previously MEN2B) due to RET mutations; and MEN4 due to cyclin-dependent kinase inhibitor (CDNK1B) mutations.
    [Show full text]
  • SOLOMON A. BERSON April 22,1918-April 11,1972
    NATIONAL ACADEMY OF SCIENCES S OLOMON A. BERSON 1918—1972 A Biographical Memoir by J . E . R A L L Any opinions expressed in this memoir are those of the author(s) and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoir COPYRIGHT 1990 NATIONAL ACADEMY OF SCIENCES WASHINGTON D.C. SOLOMON A. BERSON April 22,1918-April 11,1972 BY J. E. RALL OLOMON A. BERSON was born April 22, 1918, in New SYork City. His father, a Russian emigre who studied chem- ical engineering at Columbia University, went into business and became a reasonably prosperous fur dyer and the owner of his own company. He was a competent mathematician, enjoyed chess, and played duplicate bridge sufficiently well to become a life master. Solomon Berson—Sol to his many friends—was the eld- est of three children: Manny, the second, became a dentist; Gloria, the youngest, married Aaron Kelman, a physician and a friend of Sol's. In 1942 Sol married Miriam (Mimi) Gittleson. They had two daughters whom Sol adored, and a happy, warm family life. Sol discovered a taste and aptitude for music early in life. He played in chamber music groups in high school and de- veloped into an accomplished violinist. My impression has always been that he liked the presto movements best—he clearly led his entire life at a presto pace. He also played chess in high school and became sufficiently expert to play multiple games blindfolded. In 1934 he entered the City College of New York and, in 1938, received his degree.
    [Show full text]
  • Berson, Yalow, and the JCI: the Agony and the Ecstasy
    Berson, Yalow, and the JCI: the agony and the ecstasy C. Ronald Kahn, Jesse Roth J Clin Invest. 2004;114(8):1051-1054. https://doi.org/10.1172/JCI23316. Retrospectives The isolation of insulin in 1921 by Banting, Best, Collip, and Macleod stands as one of the most dramatic stories in modern medical investigation. Only two years passed between the initial experiments in dogs to widespread human application to the awarding of the Nobel Prize in 1923. Insulin-related research has also served as a focus, at least in part, for the work of three other Nobel Prize recipients: determination of the chemical structure of insulin by Frederick Sanger in 1958; determination of the three-dimensional structures of insulin and vitamin B12 by Dorothy Hodgkin in 1964; and finally, the development of immunoassay by Solomon Berson and Rosalyn Yalow in 1959–1960, which led to a Nobel Prize for Yalow in 1977 (five years after the untimely death of Berson). The history of Yalow and Berson’s discovery and its impact on the field is an illustration of the adage that every story has two sides. Find the latest version: https://jci.me/23316/pdf 1924–2004 Berson, Yalow, and the JCI: the agony and the ecstasy C. Ronald Kahn1 and Jesse Roth2,3 1Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA. 2Institute for Medical Research, North Shore–Long Island Jewish Health System, New Hyde Park, New York, USA. 3Albert Einstein College of Medicine, New York, New York, USA. The isolation of insulin in 1921 by Banting, Best, Collip, and Macleod stands that the school would have no obligation in as one of the most dramatic stories in modern medical investigation.
    [Show full text]
  • Intrathyroidal Clear Cell Tumor of Parathyroid Origin with Review of Literature
    Hindawi Publishing Corporation Case Reports in Pathology Volume 2016, Article ID 7169564, 7 pages http://dx.doi.org/10.1155/2016/7169564 Case Report Intrathyroidal Clear Cell Tumor of Parathyroid Origin with Review of Literature Daniela Pirela,1 Daniela Treitl,2 Siba El Hussein,3 Robert Poppiti,3 Thomas Mesko,2 and Alex Manzano4 1 Mount Sinai Medical Center, Internal Medicine Department, 4300 Alton Road, Miami Beach, FL, USA 2Mount Sinai Medical Center, Surgery Department, Miami Beach, FL, USA 3Mount Sinai Medical Center, Pathology Department, Miami Beach, FL, USA 4The Thyroid, Parathyroid and Pituitary Center for Miami, Internal Medicine Department, Miami Beach, FL, USA Correspondence should be addressed to Daniela Pirela; [email protected] Received 18 July 2016; Revised 27 October 2016; Accepted 1 November 2016 Academic Editor: Yoji Nagashima Copyright © 2016 Daniela Pirela et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Water-clear cell adenoma (WCCA) of the parathyroid gland is an exceedingly rare neoplasm. To date, 17 cases have been reported in the literature, with only one of them being intrathyroidal. Here we report a case of a 34-year-old woman who presented for evaluation of a goiter and was found to have a thyroid nodule and abnormal thyroid function tests (TFT). Fine needle aspiration biopsy of the nodule revealed thyroid follicular cells without atypia and subsequent Afirma5 Gene Expression Classifier (GEC) testing results were suspicious for malignancy. As a result, the patient underwent a right thyroid lobectomy and isthmusectomy.
    [Show full text]
  • Essentials of Head and Neck Needle Aspiration Cytology
    ESSENTIALS OF HEAD AND NECK CYTOLOGY - ESSENTIALS OF HEAD AND NECK CYTOLOGY Gia-Khanh Nguyen 2009 1 ESSENTIALS OF HEAD AND NECK CYTOLOGY ESSENTIALS OF HEAD AND NECK CYTOLOGY Gia-Khanh Nguyen, M.D. Professor Emeritus Laboratory Medicine and Pathology University Of Alberta Edmonton, Alberta, Canada Copyright by Gia-Khanh Nguyen First edition, 2009. All right reserved. This monograph was legally deposited at Library and Archives Canada and was given an ISBN: 0-9780929-1-0 2 ESSENTIALS OF HEAD AND NECK CYTOLOGY TABLE OF CONTENTS Preface…………………………………………………………………………4 Contributors…………………………………………………………………… 5 Acknowledgments……………………………………………………………….6 Related Material…………………………………………………………………...6 Dedication………………………………………………………………………………7 Chapter 1: Thyroid………………………………………………………..............8 Chapter 2: Salivary glands and other neck masses…………………………40 Chapter 3: Lymph nodes…………………………………………………………………82 Chapter 4: Intracranial tumors…………………………………………………………105 3 ESSENTIALS OF HEAD AND NECK CYTOLOGY PREFACE Tumors arising from the head and neck are numerous and have complicated and diversified histopathologic patterns. Cytodiagnosis of those neoplasms by fine needle aspiration is challenging and compounded with diagnostic pitfalls. However, with a representative cell sample and careful evaluation of different cellular and non-cellular components, a correct diagnosis may be safely made in the majority of cases. This monograph is written for practicing pathologists in community hospitals, pathology residents and cytotechnologists who are interested in acquiring a basic knowledge in diagnostic cytology of head and neck tumors. It consists of four chapters describing the cytologic manifestations of important tumors of the thyroid, parathyroid, salivary glands, lymph nodes, soft tissues and brain. The text is concise and illustrations are abundant. For most tumors, cytologic and histologic images are presented side by side for cytohistologic correlation.
    [Show full text]
  • L@€•@ Awardcitation-I
    Georg de Hevesy Nuclear Medicine Pioneer AwardCitation-I 986 Rosalyn S. Yalow and Solomon A. Berson days, we had assays scheduled and Sol would join in pipetting sample after sample, sometimes timing how long it took to do a rack of test tubes and coming up with schemes to accelerate the number of samples we could handle each hour. On other nights, he would pause to review data. One evening, I had just finished extracting insulin from an islet cell tumor in prepara tion to identify and characterize human proinsulin. The next step was to lypholize, or freeze dry, the tumor extract so as to reduce the volume. As it was 10:00 p.m., I was preparing to freeze the sample and pick up where I left off the next day. Sol walked into my lab and asked what I was doing? I was pleased to be at such a significant step . and I think he was pleased . but he was surprised that I would stop at that point. So at 10:30 p.m., the two of us assembled vacuum tubing to every aspirator in the lab to create the vacuum necessary to reduce the sample volume. If it had been his sample, I'm convinced he would have worked continuously until human proinsulin was confirmed and the struc ture characterized. L@―@ RosalynS. Yalow,PhD,NobelLaureatein Medicineand Physiology, 1977. n preparing this tribute to the 1986 Hevesy Nuclear Pioneers my task brought to mind the dilemma of I “Salieri―in “Amadeus―(1 ). I share with Salieri the frustration of explaining to others with words what it rr was like to behold genius; two fellow humans with a inexhaustible capacity for hard work and creativity, with a talent for knowing the right experiment to do, ./ for grasping the significance of the findings, for writing manuscripts with clarity and speed, with a love and excitement for exploring, for creating, for teaching oth ers.
    [Show full text]
  • Delayed Surgery for Parathyroid Adenoma Misdiagnosed As a Thyroid Nodule and Treated with Radiofrequency Ablation
    Case Endocrinol Metab 2013;28:231-235 http://dx.doi.org/10.3803/EnM.2013.28.3.231 Report pISSN 2093-596X · eISSN 2093-5978 Delayed Surgery for Parathyroid Adenoma Misdiagnosed as a Thyroid Nodule and Treated with Radiofrequency Ablation Ho-Su Kim1, Bong Hoi Choi2, Jung Rang Park1,3, Jong Ryeal Hahm1,3, Jung Hwa Jung1,3, Soo Kyoung Kim1,3, Sungsu Kim1, Kyong-Young Kim1, Soon Il Chung1, Tae Sik Jung1,3 Departments of 1Internal Medicine, 2Nuclear Medicine, 3Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Korea Primary hyperparathyroidism occurs as a result of isolated parathyroid adenoma in 80% to 85% of all cases. A 99mtechnetium (99mTc) sestamibi scan or neck ultrasonography is used to localize the neoplasm prior to surgical intervention. A 53-year-old female was referred for the exclusion of metabolic bone disease. She presented with low back pain that had persisted for the past 6 months and elevated serum alkaline phosphatase (1,253 IU/L). Four years previously, she had been diagnosed at a local hospital with a 2.3-cm thyroid nodule, which was determined to be pathologically benign. Radiofrequency ablation was performed at the same hospital because the nodule was still growing during the follow-up period 2 years before the visit to our hospital, and the proce- dure was unsuccessful in reducing the size of the nodule. The results of the laboratory tests in our hospital were as follows: serum calcium, 14.6 mg/dL; phosphorus, 3.5 mg/dL; and intact parathyroid hormone (iPTH), 1,911 pg/mL.
    [Show full text]
  • International Journal of Infection Prevention Issn No: 2690-4837
    Freely Available Online INTERNATIONAL JOURNAL OF INFECTION PREVENTION ISSN NO: 2690-4837 Research DOI: 10.14302/issn.2690-4837.ijip-20-3176 The Genetic Multiplicity- Multiple Endocrine Neoplasia type I Anubha Bajaj1,* 1MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road, Rajouri Garden, New Delhi, 110027, India Abstract Multiple endocrine neoplasia type 1 (MEN1) is a syndrome emerging from characteristic mutations of MEN1 gene with concurrently enunciated multiple endocrine and tumours and associated non-endocrine neoplasm. Previously designated as Werner’s syndrome, MEN1 syndrome denominates genomic mutation within chromosome 11q13 or a tumour suppressor gene with a distinctive protein product nomenclated as “menin”. MEN1 syndrome demonstrates an autosomal dominant pattern of disease inheritance where genomic mutations delineate a comprehensive (100%) disease penetrance. MEN1 gene was initially identified in 1997 upon chromosome 11q13. Although twelve genetic mutations were primarily identified, currently beyond eighteen hundred genomic mutations are scripted [1,2]. MEN1 syndrome is comprised of diverse combination of twenty or more endocrine and non-endocrine tumours exemplifying a classic triad of pituitary, parathyroid and pancreatic neoplasm. Diverse non endocrine tumours enunciated with MEN1 syndrome are denominated with meningioma, ependymoma or angiofibroma [1,2]. Endocrine tumours are discerned on account of excessive hormonal secretion engendered from various neoplasm or on account of neoplastic evolution. Approximately 10% instances can occur due to a de-novo genomic variant. Offspring of an individual with MEN1 syndrome quantifies a 50% possibility of inheriting the genomic variant. Cogent prenatal diagnosis can be determined in instances where specific genomic variant of a particular family is known.
    [Show full text]
  • Atypical Parathyroid Adenomas: Challenging Lesions in the Differential Diagnosis of Endocrine Tumors
    26 7 Endocrine-Related F Cetani et al. Atypical parathyroid 26:7 R441–R464 Cancer adenomas REVIEW Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors Filomena Cetani1, Claudio Marcocci2, Liborio Torregrossa3 and Elena Pardi2 1University Hospital of Pisa, Unit of Endocrinology, Pisa, Italy 2Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy 3University Hospital of Pisa, Division of Surgical Pathology, Pisa, Italy Correspondence should be addressed to F Cetani: [email protected] Abstract Atypical parathyroid adenomas represent a group of intermediate form of parathyroid Key Words neoplasms of uncertain malignant potential which show some atypical histological f parathyroid adenoma features that represent a challenge for the differential diagnosis with parathyroid f parathyroid carcinoma carcinomas. They may occur as sporadic or as a part of hereditary syndromes. The f primary molecular signature of these neoplasms is still unknown and the germline CDC73 hyperparathyroidism mutations appears to be the most common anomaly in this setting suggesting that f CDC73 these cases might represent variants of the hyperparathyroidism-jaw tumor syndrome. f parafibromin The identification of markers predicting the outcome is of great importance to guide an f PGP9.5 adequate postoperative monitoring and, the same time, relieve of the anxiety of relatively f galectin-3 strict monitoring patients not at risk. This review will summarize the current knowledge of the clinical, biochemical, molecular and histological profile of atypical parathyroid adenomas. Endocrine-Related Cancer (2019) 26, R441–R464 Introduction Parathyroid tumors are a heterogeneous group of tumors type 4 (MEN4) and the hyperparathyroidism-jaw tumor that affect 0.1–0.3% of the general population.
    [Show full text]
  • Sleep Disorders in Cervical Dystonia, Parkinson's Disease and Depression
    Southeastern European Medical Journal (SEEMEDJ) Published by University Josip Juraj Strossmayer Osijek Faculty of Medicine Osijek Editor-in-Chief Ines Drenjančević, MD, PhD, Osijek, Croatia Editorial Board Selma Uzunović, MD, PhD, Zenica, Bosnia and Herzegovina Dolores Biočina-Lukenda, MD, PhD, Split, Croatia Irena Drmić Hofman, MD, PhD, Split, Croatia Pavo Filaković, MD, PhD, Osijek, Croatia Ljubica Glavaš-Obrovac, MSc, PhD, Osijek, Croatia Nandu Goswami, MD, PhD, Graz, Austria Mitja Lainšćak, MD, PhD, Ljubljana, Slovenia Helena Lenasi, MD, PhD, Ljubljana, Slovenia Julian H. Lombard, PhD, Milwaukee, WI, USA Peter Nemeth, MD, PhD, Pécs, Hungary Shane A. Phillips, MSc, PhD, Chicago, Illinois, USA Rostyslav Stoika, PhD, Dr. Sci, Lviv, Ukraine Sandor G. Vari, MD, Los Angeles, CA, USA Aleksandar Včev, MD, PhD, Osijek, Croatia Oksana Zayachkivska, MD, PhD, DSc, Lviv, Ukraine George Wu, MD, PhD, Farmington, CT, USA Secretary: Marija Raguž, PhD English Language Proofreaders: AdHoc Cover: minimal.com.hr Technical Editors: minimal.com.hr Web page: minimal.com.hr Published online: http://seemedj.mefos.unios.hr ISSN 2459-9484 Contents Experimental Liver Peroxidation Against the Background of Limb Ischemia - Reperfusion Injury – Is There a Pathogenic Difference Between Its Modifications? .......................................... 1 Stature Estimation from the Right External Ear of Undergraduate Students in South-East Nigeria ........................................................................................................................................................................................
    [Show full text]
  • Miscp101.Pdf
    Animal Health in Minnesota Annual Report of the Minnesota Veterinary Diagnostic Laboratory Fiscal Year 1999 (July 1, 1998- June 30, 1999) in cooperation with Department of Veterinary Diagnostic Medicine College of Veterinary Medicine University of Minnesota and Minnesota Board of Animal Health Miscellaneous Publication 101-1999 Minnesota Agricultural Experiment Station University of Minnesota St. Paul, Minnesota The University of Minnesota, including the Minnesota Agricultural Experiment Station, is committed to the policy that all persons shall have equal access to its programs, facilities, and employment without regard to race, color, creed, religion, national origin, sex, marital status, disability, public assistance status, veteran status, or sexual orientation. -Printed on Recycled Paper Containing a Minimum of 10 Percent Post-Consumer Material- FOREWORD The Veterinary Diagnostic Laboratory (VDL) is a program of the College of Veterinary Medicine in the University of Minnesota Academic Health Center. The VDL was established in 1904 in the Agricultural Experiment Station of the University of Minnesota, by agreement between the Minnesota Livestock Sanitary Board and the University. It's purpose is to satisfy the need for accurate diagnosis of animal diseases that threaten Minnesota's livestock and poultry industries, companion animals, wildlife and human health. As the official laboratory of the Minnesota Board of Animal Health, the VDL provides laboratory support to the state's animal disease control and eradication programs. The VDL was administratively separated from the College's Department of Veterinary Diagnostic Medicine on July 1, 1998. This was done to enhance the interdisciplinary service and research through the participation of faculty across several non-traditional Collegiate and University departments.
    [Show full text]